Psychedelic-Assisted Therapy Through an ACT Lens: Preparation, Dosing, and Integration

Dates and Location of this VIRTUAL 2-Day Workshop:

VIRTUAL LIVE online via Zoom
Recordings will be available through 25 June 2026. We regret that we are unable to provide extended access to any registrant beyond 25 June.

Automated Zoom captioning and automated Zoom translation available.

Friday, 5 June from 14:00 - 18:00 UTC/GMT +2 (Central European Summer Time) - click here to convert to your time zone
Saturday, 6 June from 14:00 - 18:00 UTC/GMT +2 (Central European Summer Time) - click here to convert to your time zone
Contact Hours: 7.5

Workshop Leaders:


Brian Pilecki, Ph.D.	Jason Luoma, Ph.D.	Temple Morris, LCSW-C	Jenna LeJeune, Ph.D.	Miranda Morris, Ph.D.

Workshop Description:

As psychedelic-assisted therapy moves toward broader accessibility, this two-day workshop equips clinicians with an ACT framework for understanding and discussing psychedelic-assisted therapy (PAT) with clients. Led by clinician-researchers with extensive experience integrating ACT and psychedelics in clinical trials, retreats, and psychotherapy, participants will explore how psychological flexibility processes provide a coherent model for understanding PAT's mechanisms and applications through the EPPC framework (Embodiment, Perspective, Purpose, Connection)—an adaptation of ACT for psychedelic contexts. Clinicians familiar with ACT will find EPPC a natural extension of concepts they already use, while those new to ACT will appreciate EPPC's pragmatic, clinically intuitive approach that can be readily applied without extensive prior training.
The workshop reviews recent psychedelics research, the evolving legal landscape, and risks and benefits across substances (psilocybin, MDMA, ketamine), while addressing foundational elements of the clinical PAT model. Diversity, equity, and cultural humility considerations will be integrated throughout, including access barriers for underserved populations and risks of cultural appropriation. Participants will learn how psychedelics may enhance psychological flexibility and how EPPC principles guide preparation, dosing support, and integration.
Through didactic presentation, case examples, and experiential exercises, clinicians will develop practical tools for having informed conversations with interested clients and supporting them through psychedelic experiences in clinical trials, legal settings, or integration-focused work.

About the Workshop Leaders:

Brian Pilecki, Ph.D.: Dr. Brian Pilecki is the Clinical Services Manager and an Associate Scientist at the Portland Institute of Psychedelic Science, a subsidiary of Portland Psychotherapy Therapy Clinic, Research, and Training Center. He is an active researcher and a study therapist on several clinical trials including the investigation of the use of MDMA-assisted therapy for the treatment of social anxiety disorder. Brian is also an instructor for Fluence, a leading psychedelic training organization where he provides training to psilocybin facilitators in state-level programs or to study therapists in clinical trials across the country. He is co-founder of Perspective Retreats which offers group psilocybin retreats in the Netherlands, and provides psilocybin facilitation to individuals and groups in the state of Oregon. Brian is a co-founder of Portland Integration Network, a network of professionals offering specialized care related to p sychedelics in Oregon. He is also the author of the book ACT-Informed Exposure for Anxiety and co-host of Altered States of Context, a podcast about psychotherapy and psychedelics.
Jason Luoma, Ph.D.: Jason Luoma, Ph.D. is Director of Research at the Portland Institute for Psychedelic Science (https://www.pipsinstitute.com/) and CEO of Portland Psychotherapy Clinic, Research, & Training Center in Portland, OR, a social enterprise that generates revenue to support research. He is also Associate Scientist at the Oregon Research Institute and affiliate faculty at the Oregon Health Sciences University.
His research focuses on shame, self-stigma, connection, and the application psychedelic assisted therapy and Acceptance and Commitment Therapy (ACT) as an intervention for reducing shame and increasing self-compassion. He was the principal investigator of a recently completed trial of MDMA-assisted therapy for social anxiety disorder and is an investigator on a soon to launch open trial of psilocybin-assisted therapy for chronic pelvic pain. He co-founded the Open Psychedelic Evaluation Nexus (OPEN), a practice-research network that is studying the implementation of supported psilocybin services in Oregon.
He is an internationally recognized trainer in ACT and past president of the Association for Contextual Behavioral Science. He has over 80 peer-reviewed publications and has co-authored two books: Learning Acceptance and Commitment Therapy and Values in Therapy. He provides psychedelic-assisted therapy training for therapists via Perspective Retreats
Temple Morris, LCSW-C: Temple Morris, LCSW-C, is co-founder of True North Therapy & Training, a group dedicated to sharing contextual behavioral therapies with clients, practitioners, and the broader community. As a therapist, she specializes in Acceptance and Commitment Therapy (ACT) and Psychedelic Harm Reduction and Integration (PHRI), and provides clinical supervision and consultation in both modalities. Temple works as a Consultant Therapist at Sunstone Therapies, providing psychedelic-assisted therapy to study participants with PTSD and treatment-resistant depression. She co-founded Perspective Retreats, which offers ACT-informed experiential training to help professionals support psychedelic experiences safely and effectively. She also co-founded Psychedelic Assisted Therapy and Healing (PATH), a nonprofit working to make legal psychedelic therapy accessible and affordable. Temple serves as co-chair of the ACBS Psychedelic Special Interest Group boar d, where she co-leads monthly ACT-informed PHRI peer consultation groups
Jenna LeJeune, Ph.D.: Jenna LeJeune, Ph.D. is President and co-founder of Portland Psychotherapy Clinic, Research and Training Center in Portland, Oregon. She is also a study therapist at the Portland Institute for Psychedelic Science where she is involved in various clinical trials involving psychedelic-assisted psychotherapy. She is a co-founder of Perspective Retreats where she is involved in running ACT-based psychedelic training retreats for mental health professionals. As a licensed psychologist, Jenna is deeply interested in issues related to meaning, purpose, belonging, and values. She is the co-author of the book Values in Therapy: A Clinician's Guide to Helping Clients Explore Values, Increase Psychological Flexibility, and Live a More Meaningful Life as well as numerous other book chapters, journal articles, and other publications. Dr. LeJeune is also an ACBS Fellow and a peer-reviewed ACT trainer and provides ACT trainings for professionals around the world.
Miranda Morris, Ph.D.: Miranda Morris, PhD is a psychologist in Bethesda, MD and a Peer Reviewed ACT Trainer who conducts regular workshops in Acceptance and Commitment Therapy (ACT) and related therapies including Functional Analytic Psychotherapy (FAP). She is currently a Past President of the Board of the Association of Contextual Behavioral Science (ACBS). In addition, Miranda is a co-founder and trainer with Perspective Retreats, an organization which offers professional training retreats integrating ACT with psychedelic-assisted psychotherapy. She is the clinical director and co-founder of True North Therapy and Training, a group dedicated to sharing contextual behavioral therapies with clients, practitioners, and the broader community.

Following this workshop participants will be able to:

Describe the current state of psychedelics research across mental health conditions.
Explain how psychedelics may enhance psychological flexibility through increased embodied awareness, perspective-shifting, values clarity, and meaningful connection.
Map EPPC’s four core processes onto therapeutic change mechanisms in psychedelic-assisted therapy.
Identify three key components of the PAT model.
Identify at least three potential therapeutic benefits of PAT.
Identify at least 3 risks of PAT.
Identify 3 ACT principles, metaphors, and experiential techniques specifically adapted for psychedelic preparation and integration work.
Describe 3 ethical considerations for clinical practice.
Identify three issues related to cultural humility, diversity, equity, and risks of cultural appropriation in psychedelic-assisted therapy contexts.
Explain three ways in how to use EPPC to support clients in translating peak psychedelic experiences into sustained psychological flexibility and meaningful behavioral change.

Target audience: Beginner, Intermediate, Clinical

Components: Literature review, Experiential exercises, Didactic presentation, Case presentation, Role play

Topic Areas: Clinical

Package Includes: A general certificate of attendance

CE Credit Hours Available (7.5 hours): CEs for psychologists
CEs are not available for recorded viewing.

DarcyG February 3, 2026 - 9:02am